−0.62USD
−50.98 MUSD
90.47 MUSD
74.69 M
About Nxera Pharma Co.,Ltd.
Sector
CEO
Chris Cargill
Headquarters
Tokyo
Website
Employees (FY)
350
Founded
2002
ISIN
JP3431300007
FIGI
BBG000C0N8Z4
Nxera Pharma Co., Ltd. engages in the discovery, design, and development of medicines targeting G protein-coupled receptors (GPCRs). The company engages in the research, development and sales of medicines; management of regenerative medical funds; investment in bio venture companies related to regenerative medicines; overseas development by licensing; promotions of commercialization; structural analysis of GPCR; initial lead compound creation; candidate search by proprietary StaR (Stabilised Receptor) technology; as well as structural base of new drugs using GPCR related basic technology drug discovery and screening and promotions of antibody drug research and development. The company was founded by Shinichi Tamura and Takaya Nakamura on June 22, 1990 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SOLTF is 9.72 USD — it has decreased by 6.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Nxera Pharma Co.,Ltd. stocks are traded under the ticker SOLTF.
Nxera Pharma Co.,Ltd. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
SOLTF stock is 7.41% volatile and has beta coefficient of 0.65. Check out the list of the most volatile stocks — is Nxera Pharma Co.,Ltd. there?
One year price forecast for Nxera Pharma Co.,Ltd. has a max estimate of 25.69 USD and a min estimate of 9.88 USD.
SOLTF earnings for the last quarter are −0.40 USD per share, whereas the estimation was 0.21 USD resulting in a −295.37% surprise. The estimated earnings for the next quarter are 0.03 USD per share. See more details about Nxera Pharma Co.,Ltd. earnings.
Nxera Pharma Co.,Ltd. revenue for the last quarter amounts to 22.27 M USD despite the estimated figure of 46.84 M USD. In the next quarter revenue is expected to reach 44.45 M USD.
Yes, you can track Nxera Pharma Co.,Ltd. financials in yearly and quarterly reports right on TradingView.
SOLTF stock has fallen by 6.90% compared to the previous week, the month change is a 9.55% fall, over the last year Nxera Pharma Co.,Ltd. has showed a 49.19% decrease.
SOLTF net income for the last quarter is −1.47 M USD, while the quarter before that showed −32.96 M USD of net income which accounts for 95.53% change. Track more Nxera Pharma Co.,Ltd. financial stats to get the full picture.
Today Nxera Pharma Co.,Ltd. has the market capitalization of 873.77 M, it has decreased by 0.71% over the last week.
No, SOLTF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SOLTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nxera Pharma Co.,Ltd. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 350.00 employees. See our rating of the largest employees — is Nxera Pharma Co.,Ltd. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nxera Pharma Co.,Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nxera Pharma Co.,Ltd. stock shows the sell signal. See more of Nxera Pharma Co.,Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Nxera Pharma Co.,Ltd. future price: according to them, SOLTF price has a max estimate of 25.69 USD and a min estimate of 9.88 USD. Read a more detailed Nxera Pharma Co.,Ltd. forecast: see what analysts think of Nxera Pharma Co.,Ltd. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Nxera Pharma Co.,Ltd. EBITDA is −53.44 M USD, and current EBITDA margin is −51.56%. See more stats in Nxera Pharma Co.,Ltd. financial statements.